Clarivate Plc
NYSE:CLVTInformation Technology Services
-$0.10 today
- Market cap
- $1.38B
- Beta
- 1.37
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$0.21
Volume 3.95M
Average 5.22M
CLVT Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Clarivate PlcNYSE: CLVT
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables growth accelerates
Q1 FY2026 accounts receivables of $62.3M (cash outflow) rose 85.4% year over year, ahead of the +81.6% change in trailing-twelve-month accounts receivables. Sequentially, it rose 904.8% from the prior quarter. Over 3 fiscal years it compounded at -43.9% a year.
Context
- Accounts receivables amounted to 0.2% of revenue in FY2025, down 3.4 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +85.4% holds above the trailing-twelve-month pace of +81.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (5M) USD
- Year-over-year change
- -105.4%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (5M) | -105.4% |
| FY2024 | 2024-12-31 | 92.6M | +463.1% |
| FY2023 | 2023-12-31 | (25.5M) | +9.9% |
| FY2022 | 2022-12-31 | (28.3M) | +55.9% |
| FY2021 | 2021-12-31 | (64.1M) | — |
Accounts Receivables vs competitors
How CLVT compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +81.6% is the 4th highest of 7, against a peer median of +93.8%.
- Accounts receivables amounts to 1.2% of revenue for CLVT, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $62.7M USD | +149.8% | -24.3% | 0.6% | |
| LTM Dec 2025 | $52.35M USD | — | — | 1.9% | |
| LTM Apr 2026 | $36.49M USD | +500.1% | — | 14.6% | |
| LTM Mar 2026 | $34.89M USD | +37.8% | -17.3% | 2.7% | |
| LTM Mar 2026 | $28.7M USD | +81.6% | -43.9% | 1.2% | |
| LTM Jun 2026 | $13.5M USD | -17.8% | — | 4.3% | |
| LTM Mar 2026 | $11.24M USD | +337.3% | — | 8.8% | |
| LTM Sep 2026 | $1M USD | — | -10.6% | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CN¥0 CNY | -100.0% | +18.2% | 0.0% | |
| Peer median (excluding CLVT) | — | +93.8% | -14.0% | 1.9% | |
Competitors are the stored peer set for CLVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (270.5M) | (3.96B) | (911.2M) | (636.7M) | (201.1M) |
| Depreciation & Amortization | 537.8M | 710.5M | 708.3M | 727M | 757.2M |
| Deferred Income Tax | (13.3M) | (54.3M) | (78.4M) | 21.2M | (41.5M) |
| Stock-Based Compensation | 33.3M | 93.9M | 109M | 59.9M | 63.1M |
| Change in Working Capital | 68M | (271.9M) | (60.4M) | (24.9M) | 3.5M |
| Accounts Receivables | (64.1M) | (28.3M) | (25.5M) | 92.6M | (5M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 31.2M | (24M) | 41.2M | (15M) | 22.8M |
| Other Working Capital | 100.9M | (219.6M) | (76.1M) | (102.5M) | (14.3M) |
| Other Non-Cash Items | (31.5M) | 3.99B | 976.9M | 500.1M | 47.3M |
| Operating Cash Flow | 323.8M | 509.3M | 744.2M | 646.6M | 628.5M |
| Capital Expenditures | (118.5M) | (202.9M) | (242.5M) | (289.1M) | (263.2M) |
| Acquisitions (Net) | (3.93B) | 260.2M | 5.1M | (32M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 84.4M | 0 |
| Investing Cash Flow | (4.04B) | 57.3M | (237.4M) | (236.7M) | (263.2M) |
| Debt Repayment | 1.99B | (496.5M) | (301M) | (198.1M) | (109.4M) |
| Common Stock Issued | 867.9M | 5.7M | 0 | 0 | 0 |
| Common Stock Repurchased | (159.4M) | (175M) | (100M) | (200M) | (224.5M) |
| Dividends Paid | (18.9M) | (75.4M) | (75.5M) | (37.7M) | 0 |
| Other Financing Activities | (38.8M) | (12.3M) | (20.5M) | (34.3M) | (9.2M) |
| Financing Cash Flow | 4.03B | (759.2M) | (496.5M) | (470.1M) | (343.1M) |
| Effect of Forex Changes | 3.7M | (38.2M) | 3.6M | (15.3M) | 11.8M |
| Net Change in Cash | 315.2M | (230.8M) | 13.9M | (75.5M) | 34M |
| Free Cash Flow | 205.3M | 306.4M | 501.7M | 357.5M | 365.3M |
Clarivate Plc
NYSE:CLVT
Intrinsic Alpha fair value
Locked
Current Price
$2.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.